Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





BD Presents Latest Innovations in Patient Safety at Arab Health and MEDLAB Middle East

By LabMedica International staff writers
Posted on 24 Jan 2022

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) participated and shared insights with cutting-edge technology solutions enhancing the patient care journey at this year’s Arab Health and MEDLAB 2022 held at the Dubai World Trade Centre. More...

BD presented its latest innovations and solutions focused on patient safety to support clinicians’ efforts to move from piecemeal interventions to a total systems approach for safety at two of the region’s leading medical technology events. At Arab Health 2022, the company demonstrated the full potential of its innovations through the collaboration of its Medical segment with Medication Management Systems and Medication Delivery Systems, and the BD Interventional segment. BD displayed a series of solutions that focused on the prevention of potential medication errors and Healthcare-Associated Infections (HAIs) alongside innovations that empower medical professionals to perform timely, accurate and appropriate diagnostics practices to support effective decision making in providing the safest and most effective care possible in the region.

Additionally, at MEDLAB 2022, the company’s Lifesciences segment showcased integrated diagnostic solutions and services, including safe and integrated specimen collection, specimen diagnosis and data management for better patient comfort. The company also presented solutions that incorporate artificial intelligence to drive laboratory efficiency with customized microbiology automation platforms and dedicated value-added services. Additionally, experts from BD hosted several sessions that addressed the challenges in patient and healthcare worker safety in the post pandemic world. They also highlighted the best practices and demonstrated a variety of services and solutions to help equip healthcare providers in the region with the safe tools leading to better medication management decisions and patient treatment outcomes.

“The pandemic put the healthcare sector to the test in terms of stability and preparedness, demonstrating the need for healthcare providers to adopt advanced technology to meet the growing needs of patients,” said Maher Elhassan, Vice President and General Manager, BD Middle East, North Africa, and Turkey. “Avenues like Arab Health and Medlab give us an invaluable opportunity to raise awareness while facilitating the necessary impetus to our movement of securing and improving the patient care journey for both medical professionals and patients alike. Now more than ever, is the time for organizations and medical institutions to collaborate and achieve greater milestones in patient safety and BD will do everything in its capacity to provide best-in-class MedTech products and services, as we pursue our purpose of advancing the world of health.”

Related Links:
Becton, Dickinson and Company


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.